Connect with us
DAPA Banner
DAPA Coin
DAPA
COIN PAYMENT ASSET
PRIVACY · BLOCKDAG · HOMOMORPHIC ENCRYPTION · RUST
ElGamal Encrypted MINE DAPA
🚫 GENESIS SOLD OUT
DAPAPAY COMING

Business

ACADIA Pharmaceuticals Stock Soars Over 12% After EU Regulators Reverse Course on Rett Syndrome Drug

Published

on

Abbott Laboratories Shares Rise as Medical Device and Diagnostics Giant

Shares of ACADIA Pharmaceuticals surged Friday, climbing 12.65%, or $3.00, to $26.72 in midday trading, after European regulators reversed an earlier rejection of the company’s flagship Rett syndrome treatment.

The rally marks a dramatic turnaround for a stock that had been weighed down for months by uncertainty over whether the drug, trofinetide, would ever reach patients in the European Union.

A reversal months in the making

The catalyst behind Friday’s jump traces directly to a regulatory decision delivered this week. According to meeting highlights published by the European Medicines Agency, the Committee for Medicinal Products for Human Use, following a re-examination, recommended granting a marketing authorization for Daybu, the European brand name for trofinetide, for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older.

Advertisement

The decision reverses a setback that had clouded ACADIA’s European ambitions since early this year. The committee had initially adopted a negative opinion on the drug’s marketing authorization application in March 2026, prompting the company to formally request a re-examination of that decision.

What went wrong the first time

When the CHMP first rejected the application, the committee’s concerns centered on specific gaps in the clinical data rather than a wholesale dismissal of the drug’s effectiveness. The committee’s refusal was based on perceived deficits including the view that the treatment effect observed with trofinetide after 12 weeks, while measurable, was limited in magnitude; that the pivotal study did not capture all core symptoms of Rett syndrome; and that assessment of longer-term outcomes was influenced by patient discontinuations over time — even though the pivotal LAVENDER trial had successfully met its co-primary and key secondary endpoints.

ACADIA’s chief executive responded to that initial setback by emphasizing the company’s confidence in the underlying clinical data. “While we are disappointed by the CHMP’s recommendation to refuse approval, we continue to be encouraged by the meaningful benefits trofinetide has demonstrated for people living with Rett syndrome,” Catherine Owen Adams, ACADIA’s Chief Executive Officer, said at the time. “The strong engagement and positive feedback we have seen from patients, caregivers, and clinicians in the Rett community reinforce our belief in the treatment’s clinical value.”

Advertisement

A drug already approved elsewhere

Trofinetide’s path through European regulators stands in contrast to its reception in other major markets, where the drug has already secured approval and reached patients. The medicine, a synthetic version of a naturally occurring molecule known as the tripeptide glycine-proline-glutamate, was approved for the treatment of Rett syndrome in adults and pediatric patients two years of age and older by the U.S. Food and Drug Administration in March 2023 under the trade name DAYBUE, and the drug is also approved in Canada and Israel.

In the U.S., ACADIA has continued expanding the franchise around the drug even as the European process played out. The company’s newer formulation, DAYBUE STIX, a dye- and preservative-free powder version of trofinetide, became broadly available across the United States earlier this year following a limited initial launch.

A business built on two approved drugs

Advertisement

Beyond trofinetide, ACADIA’s commercial business rests on a second approved medicine targeting a different neurological condition. The company also markets NUPLAZID, a selective serotonin inverse agonist and antagonist used to treat hallucinations and delusions associated with Parkinson’s disease psychosis.

Both franchises have continued growing steadily even amid the European regulatory uncertainty. In the company’s first quarter of 2026, total revenues reached $268 million, up 11% year-over-year, with DAYBUE sales climbing 20% to $101 million and NUPLAZID sales rising 6% on a non-GAAP adjusted basis to $167 million. Management reaffirmed its full-year 2026 revenue guidance of $1.22 billion to $1.28 billion alongside those results, while reporting a robust balance sheet position of roughly $850 million in cash and no long-term debt.

A pipeline with more catalysts ahead

Friday’s regulatory win adds to a list of upcoming events that could further move the stock in the coming months. ACADIA has reaffirmed its expectation for topline results from a Phase 2 study of remlifanserin, an experimental treatment for Alzheimer’s disease psychosis, with results anticipated sometime between August and October of 2026. The company is also awaiting topline results from a trofinetide clinical trial underway in Japan, expected in the September-to-November window.

Advertisement

Not every recent pipeline update has gone ACADIA’s way, however. The company’s investigational treatment for hyperphagia in Prader-Willi syndrome, an intranasal formulation known as ACP-101, missed all of its endpoints in a Phase III trial, leading the company to end its development work on that program.

Wall Street’s view heading into the news

Even before Friday’s regulatory reversal, analysts following the stock had largely maintained an optimistic outlook on ACADIA’s prospects. Across 21 analysts tracking the stock, the average rating has stood at “Buy,” with a 12-month price target of $31.65 implying a sizable increase from recent trading levels heading into this week. Recent analyst commentary had also pointed to the stock potentially being undervalued following the company’s reaffirmed guidance, even before factoring in the European approval news.

Not all recent analyst moves had been positive, however. RBC Capital lowered its price target on ACADIA to $29 from $30 in May, while Citi separately trimmed its target to $32 from $33, even as both firms maintained bullish ratings on the stock.

Advertisement

What the European approval means going forward

While the CHMP’s recommendation represents a significant step, it is not the final word on the drug’s fate in the European market. A positive CHMP opinion typically precedes a formal decision by the European Commission, which generally follows the committee’s recommendation in granting marketing authorization across the European Union. If that authorization follows as expected, it would open the door for ACADIA to bring trofinetide to Rett syndrome patients across the European market for the first time, expanding the drug’s commercial reach well beyond the United States, Canada and Israel.

For a company whose stock has spent much of the year trading within a relatively narrow band between roughly $20 and $28, Friday’s regulatory reversal — and the sharp rally that followed it — offers a concrete sign that one of its more uncertain near-term catalysts has finally been resolved in the company’s favor.

Advertisement
Continue Reading
Click to comment

You must be logged in to post a comment Login

Leave a Reply

Business

The Dow May Finally Close Above 52,000. Fourth Time’s the Charm?

Published

on

Stocks Little Changed After Fed Decision

The blue-chip index was up 214 points, or 0.4%, to 52,060. A close above 52,000 would mark its fourth thousand-point milestone of 2026; the Dow closed above 51,000 18 trading days ago, according to Dow Jones Market Data.

This is actually the fourth time the index traded above 52,000, but it failed to hold on through the prior three occasions. Its current record close is 51,999.67.

Continue Reading

Business

Thailand Boosts Youth Protection With Safe Jobs and Skills Training

Published

on

Thailand Boosts Youth Protection With Safe Jobs and Skills Training

Labour Ministry implements three measures: safe holiday jobs, vocational training for non-students, and labour rights education. Strict child labour laws will be enforced, with workplaces encouraged to declare themselves child labour-free to boost international confidence and ensure youth well-being.


Key Points

  • The Labour Ministry is launching three proactive initiatives: promoting safe holiday work for over 10,000 students, offering vocational skills training for non-students, and educating youth on labour rights and safety to prevent exploitation.
  • Strict child labour laws, prohibiting employment under 15 and regulating work for 15-17 year olds, will be enforced. Workplaces are encouraged to declare themselves child labour-free to align with international standards.
  • This comprehensive approach emphasizes creating opportunities, education, and skill development alongside law enforcement to ensure children’s safety, well-being, and full potential.

Safe Holiday Work for Youth

The Labour Ministry is proactively addressing child labour and enhancing youth well-being through three primary initiatives. The first focuses on providing safe and legal employment opportunities during school holidays. By partnering with over 56 major national businesses, the ministry is facilitating more than 10,000 positions for students. This program enables young people to gain valuable work experience and earn income while ensuring they are protected under existing labour laws, thereby preventing them from falling into exploitative work during their breaks.

Skills Development for Future Employment

The second strategic measure targets young individuals who do not pursue further academic studies by equipping them with vocational skills. This initiative aims to facilitate a transition from unskilled labour to skilled employment, thereby improving their long-term career prospects and economic stability. Collaborating with educational institutions, the ministry will provide necessary support and training before these young people enter the formal labour market, ensuring they are better prepared and more competitive.

Empowerment Through Rights Education and Strict Enforcement

The third measure involves educating young people on their labour rights and workplace safety protocols, empowering them to recognize and resist exploitation. Complementing these proactive measures, the government reaffirms its commitment to strict enforcement of existing child labour laws, which prohibit employment for those under 15 and impose stringent welfare and safety regulations for those aged 15 to 17. Furthermore, workplaces are being encouraged to voluntarily declare themselves child-labour-free, aligning Thai labour standards with international expectations and bolstering global trade confidence.

Source : Thailand steps up child-labour protection with safe jobs and skills training

Advertisement

Continue Reading

Business

Clear Secure CEO sells $1.82m in company stock

Published

on


Clear Secure CEO sells $1.82m in company stock

Continue Reading

Business

Form 4 Clear Secure Inc For: 26 June

Published

on


Form 4 Clear Secure Inc For: 26 June

Continue Reading

Business

5G Expansion and Customer Retention

Published

on

Verizon

Verizon Communications Inc. shares rose more than 0.72 percent on Friday, closing at $46.40 after gaining $0.33, as investors responded positively to the company’s continued customer additions and network performance.

The modest advance reflected confidence in Verizon’s position as a leading wireless provider with a focus on reliability and premium services. The company has maintained steady subscriber growth while expanding its 5G network and fiber broadband offerings.

Verizon’s postpaid phone net additions have remained strong, demonstrating its appeal to consumers and businesses seeking dependable connectivity. Its emphasis on network quality and customer service has supported retention and acquisition.

The company’s diversified business model, including wireless, fiber and business solutions, provides multiple revenue streams. Strategic investments in 5G infrastructure and fiber expansion support long-term growth prospects.

Advertisement

Operational Performance

Verizon has reported consistent revenue growth driven by wireless service revenue and broadband expansion. Its ability to monetize network investments through higher-tier plans has contributed to financial improvement.

The company’s fiber business has shown strong growth as it expands availability of high-speed internet services. Fios offerings compete effectively in markets where they are available.

Enterprise solutions and business services provide additional revenue diversification. Verizon’s global network and security offerings appeal to corporate customers with complex connectivity needs.

Advertisement

Operational efficiency initiatives have helped manage costs while maintaining service quality. The company’s scale provides advantages in infrastructure deployment and customer support.

Network Leadership

Verizon has invested heavily in 5G deployment, achieving broad coverage across the United States. Its focus on millimeter wave and mid-band spectrum has enabled high-speed connectivity in various environments.

The carrier continues upgrading its network with advanced technologies including carrier aggregation and dynamic spectrum sharing. These improvements enhance capacity and performance for customers.

Advertisement

Fixed wireless access services have expanded rapidly, providing home broadband alternatives in many markets. Verizon’s 5G home internet offers competitive speeds and reliability.

The company’s network reliability and coverage have been recognized in independent studies. This reputation supports customer acquisition and reduces churn.

Strategic Initiatives

Verizon has pursued selective acquisitions and partnerships to enhance its capabilities. These moves have strengthened its position in 5G, fiber and enterprise services.

Advertisement

The company’s focus on digital transformation includes improved customer interfaces and automated service processes. These investments aim to enhance user experience and operational efficiency.

Sustainability initiatives include renewable energy adoption and responsible supply chain practices. Verizon’s environmental efforts align with corporate responsibility expectations.

Market Position and Competition

Verizon competes with T-Mobile and AT&T in the wireless market. Its emphasis on network quality and premium services differentiates it from competitors focusing on price and unlimited data.

Advertisement

The carrier’s enterprise business serves large organizations with complex connectivity requirements. Its global reach and security expertise provide competitive advantages.

Fixed broadband competition from cable providers and fiber overbuilders requires continuous investment in network capabilities. Verizon’s fiber expansion strategy addresses this competitive dynamic.

International operations, while smaller than domestic businesses, provide additional revenue and growth opportunities. Regional market conditions influence international performance.

Investment Considerations

Advertisement

Verizon’s shares appeal to income-oriented investors through its attractive dividend yield and history of consistent payouts. The stock’s defensive characteristics in the telecommunications sector provide stability.

Valuation metrics reflect expectations for steady growth and dividend support. Risks include competitive pressures, regulatory changes and execution challenges in network deployment.

Longer-term investors value Verizon’s essential service role and reliable cash flow generation. Its position in critical infrastructure supports sustained relevance.

Analysts generally maintain stable outlooks, citing the company’s network strength and customer base. Continued execution on growth initiatives could support further positive sentiment.

Advertisement

Industry Trends

The wireless industry continues evolving with 5G deployment, increasing data consumption and emerging technologies. Carriers must balance infrastructure investment with returns on capital.

Consumer demand for unlimited data and high-speed connectivity drives network capacity requirements. Verizon’s focus on premium services aligns with this trend.

Fixed wireless access represents a significant opportunity to disrupt traditional broadband markets. Successful execution in this area could diversify revenue streams.

Advertisement

Regulatory considerations around spectrum allocation and competition policy influence industry dynamics. Verizon’s advocacy for balanced regulation supports its business interests.

Future Outlook

Verizon’s strategic direction focuses on leveraging its network assets while developing new revenue streams in 5G and fiber. Its strong customer relationships and brand reputation provide foundations for continued success.

The company continues investing in network modernization and digital capabilities. Its ability to adapt to changing customer needs while maintaining service quality will influence long-term performance.

Advertisement

Investors will monitor upcoming quarterly results for progress on subscriber metrics, revenue growth and margin trends. Management guidance will provide insight into execution priorities and market conditions.

The telecommunications sector’s fundamental demand drivers remain strong. Verizon’s competitive positioning and operational capabilities suggest potential for sustained performance.

As the company advances its network and service offerings, its contribution to American connectivity and digital economy will expand. Verizon’s progress will be watched closely by industry participants and investors.

Advertisement
Continue Reading

Business

Form 4 Slide Insurance Holdings Inc For: 26 June

Published

on


Form 4 Slide Insurance Holdings Inc For: 26 June

Continue Reading

Business

Personalis CFO Aaron Tachibana sells $675,488 in company stock

Published

on


Personalis CFO Aaron Tachibana sells $675,488 in company stock

Continue Reading

Business

Form 4 Perpetua Resources Corp For: 26 June

Published

on


Form 4 Perpetua Resources Corp For: 26 June

Continue Reading

Business

Uber: I Love Buying This Dip

Published

on

Uber: I Love Buying This Dip

Uber: I Love Buying This Dip

Continue Reading

Business

STRF: Senior Preferred, Double Digit Tax Deferred Yield, High Asset Coverage (NASDAQ:STRF)

Published

on

Victory Income Fund Q4 2025 Commentary

This article was written by

Cogent investment views on digital assets, macro, and derivatives. BTC Maxi. My investment philosophy centers around deep fundamentals, impactful narratives, and Austrian economics. Time horizon is the primary dividing factor for investment research. Long-horizon research will focus on digital assets, macro, and general value opportunities. Emphasis is placed on a global, long-run macro view as the basis for these investment considerations. Short-horizon research will focus on options and volatility for income generation and hedging.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Advertisement
Continue Reading

Trending

Copyright © 2025